Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH Deficiency
The DOI matches its Crossref record; 59 of the 64 references it cites were found in a registry or an index.
Abstract
Although the use of the insulin tolerance test (ITT) for the diagnosis of adult GH deficiency is well established, diagnostic peak GH cut-points for other commonly used GH stimulation tests are less clearly established. Despite that fact, the majority of patients in the United States who are evaluated for GH deficiency do not undergo insulin tolerance testing. The aim of this study was to evaluate the relative utility of six different methods of testing for adult GH deficiency currently used in practice in the United States and to develop diagnostic cut-points for each of these tests. Thirty-nine patients (26 male, 13 female) with adult-onset hypothalamic-pituitary disease and multiple pituitary hormone deficiencies were studied in comparison with age-, sex-, estrogen status-, and body mass index-matched control subjects (n = 34; 20 male, 14 female). A third group of patients (n = 21) with adult-onset hypothalamic-pituitary disease and no more than one additional pituitary hormone deficiency was also studied. The primary end-point was peak serum GH response to five GH stimulation tests administered in random order at five separate visits: ITT, arginine (ARG), levodopa (L-DOPA), ARG plus L-DOPA, and ARG plus GHRH. Serum IGF-I concentrations were also measured on two occasions. For purposes of analysis, patients with multiple pituitary hormone deficiencies were assumed to be GH deficient. Three diagnostic cut-points were calculated for each test to provide optimal separation of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While interpreting GH values, one should also consider multiple factors, including nutritional and hormonal status, exercise, body weight, and age, all of which may influence pituitary GH secretion (85,86).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [86]
Citations
Cites
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
IRANMANESH, A., LIZARRALDE, G., & VELDHUIS, J. D. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1081 · Cited by 672 · cited 1×
“Each one unit increase in BMI has been shown to be associated with a 6% decrease in 24-h GH secretion (35).”
Background; (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.379 · Cited by 655
VELDHUIS, J. D., IRANMANESH, A., HO, K. K. Y., WATERS, M. J., JOHNSON, M. L., & LIZARRALDE, G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-51 · Cited by 480 · cited 1×
“Obesity suppresses GH release, with 24-h GH levels in obese men reduced by 75% in comparison with age-matched normal weight subjects (34).”
The Diagnosis of Growth Hormone Deficiency in Adults
Ho, K. K. Y., & Hoffman, D. M. (1997) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.6.suppl10_35 · Cited by 428
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414 · cited 4×
“Therefore, evaluation of tests designed to diagnose GHD should control for such variables (18, 19).”
BackgroundInfluentialDiagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386
Radioimmunoassays for IGFs and IGFBPs.
Blum, W. F. P., & Breier, B. H. (1994) · PubMed · Cited by 362
COPELAND, K. C., UNDERWOOD, L. E., & VAN WYK, J. J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-4-690 · Cited by 352 · cited 1×
“GH therapy was not administered for at least one month before study entry, based on data that demonstrate that serum IGF-I levels return to nearbaseline within 48 h after cessation of GH (22).”
MethodArginine Stimulates Growth Hormone Secretion by Suppressing Endogenous Somatostatin Secretion*
ALBA-ROTH, J., MÜLLER, O. A., SCHOPOHL, J., & WERDER, K. V. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-6-1186 · Cited by 337 · cited 1×
“This amino acid is believed to increase GH by suppressing endogenous somatostatin (11, 45, 46).”
Background
Research works printed but not linked: 2
- 1998, AACE clinical practice guidelines for growth hormone use in adults and children., Endocr Pract, 4, 165
- Mausner, 1974, Epidemiology, Philadelphia: W. B. Saunders;, 237
Cited by
Items 101–200 of 422
Diagnosis of adult GH deficiency
Gasco, V., Corneli, G., Rovere, S., Croce, C., Beccuti, G., Mainolfi, A., Grottoli, S., Aimaretti, G., & Ghigo, E. (2008) · Pituitary · doi:10.1007/s11102-008-0110-x · Cited by 41
“[22] who found that the best pair of sensitivity and specificity (87 and 91%, respectively) is shown by a cut-off level of 0.”
BackgroundMethodInfluentialEpilepsy, depression, and growth hormone
Butler, T., Harvey, P., Cardozo, L., Zhu, Y., Mosa, A. J., Tanzi, E. B., & Pervez, F. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.01.022 · Cited by 50
“Stimulation tests consist of serial GH serum measurements after the administration of agents, such as, insulin, GH releasing hormone (GHRH), arginine, glucagon, levodopa, or clonidine, which induce GH release via direct (as in the case of GHRH, which acts directly on somatotropic cells) or indirect mechanisms [49-51].”
BackgroundBrabant, G., Poll, E. M., Jönsson, P., Polydorou, D., & Kreitschmann-Andermahr, I. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0273 · Cited by 41
Al Mukaddam, M., Rajapakse, C. S., Bhagat, Y. A., Wehrli, F. W., Guo, W., Peachey, H., LeBeau, S. O., Zemel, B. S., Wang, C., Swerdloff, R. S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3665 · Cited by 38
Björk, J., Link, K., & Erfurth, E. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0304 · Cited by 37
Growth hormone secretion is impaired in amyotrophic lateral sclerosis
Morselli, L. L., Bongioanni, P., Genovesi, M., Licitra, R., Rossi, B., Murri, L., Rossi, G., Martino, E., & Gasperi, M. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02609.x · Cited by 41
Adult growth hormone deficiency: clinical advances and approaches to improve adherence
Yuen, K. C. J., Llahana, S., & Miller, B. S. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1689119 · Cited by 41
Pituitary Physiology and Diagnostic Evaluation
Kaiser, U. B., & Ho, K. K. Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00008-3 · Cited by 49
Diagnosing Growth Hormone Deficiency in Adults
Glynn, N., & Agha, A. (2012) · International Journal of Endocrinology · doi:10.1155/2012/972617 · Cited by 44
“It has been shown to be a less exuberant stimulant for GH secretion than the ITT or the GST [33, 37].”
BackgroundInfluentialColao, A., Di Somma, C., Spiezia, S., Rota, F., Pivonello, R., Savastano, S., & Lombardi, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2566 · Cited by 39
“(12) also previously reported similar GH cutoff in a large population of hypopituitary patients having a mean BMI of 30 kg/m(2), thus in the obese range.”
BackgroundZeinalizadeh, M., Habibi, Z., Fernandez-Miranda, J. C., Gardner, P. A., Hodak, S. P., & Challinor, S. M. (2014) · Pituitary · doi:10.1007/s11102-014-0556-y · Cited by 37
Giuliano, S., Talarico, S., Bruno, L., Nicoletti, F. B., Ceccotti, C., & Belfiore, A. (2016) · Endocrine · doi:10.1007/s12020-016-1183-3 · Cited by 41
“5 g/kg), and serum GH was measured at baseline, 30, 60 and 90 min [27, 28].”
MethodGrowth hormone status in morbidly obese subjects and correlation with body composition
Savastano, S., Somma, C. D., Belfiore, A., Guida, B., Orio, F., Rota, F., Savanelli, M. C., Cascella, T., Mentone, A., Angrisani, L., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344144 · Cited by 42
“In fact, recently, BMI has been shown to affect the GH response to the GHRH+ARG test (8, 15, 16).”
BackgroundInfluentialHam, J. N., Ginsberg, J. P., Hendell, C. D., & Moshang, T. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02272.x · Cited by 33
Utz, A. L., Yamamoto, A., Sluss, P., Breu, J., & Miller, K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0930 · Cited by 37
“GHRH (1 g/kg) plus arginine (0.5 g/kg; maximum, 30 g) was administered iv, and GH levels were drawn at baseline and every 30 min for 2 h. This test has been validated in comparison to the gold standard insulin tolerance test, with proposed cut-offs for the diagnosis of GH deficiency of 4.1 to 9 ng/ml ( 29 , 30).”
MethodInfluentialJaved, Z., Qamar, U., & Sathyapalan, T. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.167561 · Cited by 43
Berg, C., Meinel, T., Lahner, H., Mann, K., & Petersenn, S. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0997 · Cited by 36
Khajeh, L., Blijdorp, K., Heijenbrok‐Kal, M. H., Sneekes, E. M., van den Berg-Emons, R. J. G., van der Lely, A. J., Dippel, D. W. J., Neggers, S. J. C. M. M., Ribbers, G. M., & van Kooten, F. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307897 · Cited by 37
Retesting the childhood-onset GH-deficient patient
Gasco, V., Corneli, G., Beccuti, G., Prodam, F., Rovere, S., BELLONE, J., Grottoli, S., Aimaretti, G., & Ghigo, E. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0293 · Cited by 41
Significant GH deficiency after long-term cure by surgery in adult patients with Cushing’s disease
Pecori Giraldi, F., Andrioli, M., De Marinis, L., Bianchi, A., Giampietro, A., De Martin, M., Sacco, E., Scacchi, M., Pontecorvi, A., & Cavagnini, F. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02329 · Cited by 35
“In addition, the response to GHRHCarginine stimulation can be analysed according to the recently proposed weightadjusted criteria (9, 14 ).”
BackgroundInfluentialAn Update on Advances in Hypopituitarism: Etiology, Diagnosis, and Current Management
Iglesias, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206161 · Cited by 43
“Clinically, it can manifest as reduced health-related quality of life; fatigue; reduced exercise tolerance; obesity; anxiety, depression and social isolation; bone fractures; and an increased risk of cardiovascular disease [125–130].”
BackgroundDiagnosis of GH Deficiency as a Late Effect of Radiotherapy in Survivors of Childhood Cancers
Sfeir, J. G., Kittah, N. E. N., Tamhane, S. U., Jasim, S., Chemaitilly, W., Cohen, L. E., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01204 · Cited by 35
Sensitivity and specificity of the macimorelin test for diagnosis of AGHD
Garcia, J. M., Biller, B. M. K., Korbonits, M., POPOVIC, V. M., Luger, A., Strasburger, C. J., Chanson, P., Swerdloff, R. S., Wang, C., Fleming, R. R., et al. (2020) · Endocrine Connections · doi:10.1530/ec-20-0491 · Cited by 38
“As a result of these safety concerns, the ITT is contraindicated in elderly patients and in those with underlying seizure disorders or cardiovascular disease (11, 23, 24, 25).”
BackgroundMethodInfluentialSelf-citationGrowth hormone secretion among HIV infected patients: effects of gender, race and fat distribution
Koutkia, P., Eaton, K., You, S. M., Breu, J. J., & Grinspoon, S. K. (2006) · AIDS · doi:10.1097/01.aids.0000218549.85081.8f · Cited by 34
“The GHRH þ arginine test has been shown to be a reasonable alternative test to determine GH deficiency [15,28].”
Carmichael, J. D., Danoff, A., Milani, D., Roubenoff, R., Lesser, M. L., Livote, E., Reitz, R. E., Ferris, S., & Kleinberg, D. L. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02569.x · Cited by 35
Self-citationThe value of IGF1 estimation in adults with GH deficiency
Mukherjee, A., & Shalet, S. M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0247 · Cited by 36
Hannon, M. J., Orr, C. E., Moran, C., Behan, L., Agha, A., Ball, S. G., & Thompson, C. J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04270.x · Cited by 34
Molema, F., Gleich, F., Burgard, P. J., van der Ploeg, A. T., Summar, M. L., Chapman, K. A., Lund, A. M., Rizopoulos, D., Kölker, S., Williams, M., et al. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.02.003 · Cited by 39
Klose, M., Jonsson, B., Abs, R., Popovic, V, Koltowska-Häggström, M., Saller, B., Feldt-Rasmussen, U., & Kourides, I. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0328 · Cited by 31
Carlson, N. E., Brenner, L. A., Wierman, M. E., Harrison-Felix, C., Morey, C., Gallagher, S., & Ripley, D. (2009) · Brain Injury · doi:10.1080/02699050902788535 · Cited by 30
“Most researchers have also reported that IGF-1 is a poor predictor of GH deficiency and that evocative testing with growth hormone releasing hormone (GHRH) and arginine most reliably predicts dysfunction of this axis [45].”
BackgroundDarzy, K. H., Thorner, M. O., & Shalet, S. M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03359.x · Cited by 30
Dietary arginine and linear growth: the Copenhagen School Child Intervention Study
van Vught, A., Dagnelie, P. C., Arts, I. C. W., Froberg, K., Andersen, L. B., El-Naaman, B., Bugge, A., Nielsen, B., & Heitman, B. L. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512002942 · Cited by 32
“GH concentration can increase 20-fold after an intravenous arginine bolus (0·5 g/kg)((13,14)).”
BackgroundMethodAdult Growth Hormone Deficiency: Current Concepts
Fukuda, I., Hizuka, N., Muraoka, T., & Ichihara, A. (2014) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2014-0088 · Cited by 35
The Rational Use of Pituitary Stimulation Tests
Petersenn, S., QUABBE, H.-J., Schöfl, C., Stalla, G. K., von Werder, K., & Buchfelder, M. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0437 · Cited by 47
New Guidelines for the Diagnosis of Growth Hormone Deficiency in Adults
Casanueva, F. F., Castro, A. I., Micić, D., Keleştimur, F., & Diéguez, C. (2009) · Hormone Research in Paediatrics · doi:10.1159/000178051 · Cited by 30
Hwang, J. Y., Aum, D. J., Chicoine, M. R., Dacey, R. G., Osbun, J. W., Rich, K. M., Zipfel, G. J., Klatt‐Cromwell, C. N., McJunkin, J. L., Pipkorn, P. J., et al. (2020) · Pituitary · doi:10.1007/s11102-020-01045-z · Cited by 29
Growth Hormone: The Expansion of Available Products and Indications
Franklin, S. L., & Geffner, M. E. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.06.006 · Cited by 29
Quigley, C. A., Zagar, A. J., Liu, C. C., Brown, D. M., Huseman, C. A., Levitsky, L. L., Repaske, D. R., Tsalikian, E., & Chipman, J. J. (2013) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2013-6 · Cited by 31
“arginine, GH-releasing hormone, L-dopa) leaves few options other than ITT, which requires physician presence because of the risk of complications such as seizures as a result of significant hypoglycemia [24,33].”
BackgroundMethodSelf-citationWoodmansee, W. W., Hartman, M. L., Lamberts, S. W. J., Zagar, A. J., Clemmons, D. R., & on behalf of the International HypoCCS Advisory Board (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03612.x · Cited by 29
Self-citationKaramouzis, I., Pagano, L., Prodam, F., Mele, C., Zavattaro, M., Busti, A., Marzullo, P., & Aimaretti, G. (2015) · Endocrine · doi:10.1007/s12020-015-0796-2 · Cited by 28
“2 lg/L is indicative for GH deficiency in obese subjects [66].”
BackgroundGrowth Hormone Responses to Provocative Tests in Children with Short Stature
Rhee, N., Oh, K. Y., Yang, E. M., & Kim, C. J. (2015) · Chonnam Medical Journal · doi:10.4068/cmj.2015.51.1.33 · Cited by 27
“Thus, close monitoring for adverse reactions, especially for hypoglycemia during a provocation test using insulin, is needed.(27,28) In our study, among the”
BackgroundRisk factor for pituitary dysfunction in children and adolescents with Rathke's cleft cysts
Lim, H. H., & Yang, S. W. (2010) · Korean Journal of Pediatrics · doi:10.3345/kjp.2010.53.7.759 · Cited by 26
Contribution of Ghrelin to the Pathogenesis of Growth Hormone Deficiency
Lewiñski, A., Karbownik‐Lewińska, M., Wieczorek, K., Stasiak, M., & Stawerska, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169066 · Cited by 32
“1 ng/mL—Biller, 2002; Molitch, 2011 [41,47] <3 ng/mL—Ho, 2007 [42] <5 ng/mL—Yuen, 2019 [43]”
BackgroundSubarachnoid Hemorrhage As a Cause of Hypopituitarism
Kreitschmann‐Andermahr, I. (2005) · Pituitary · doi:10.1007/s11102-006-6044-2 · Cited by 29
“The ITT is less susceptible to BMI-dependent alteration of GH levels than the GHRH+ARG test [41] and is the only dynamic test of GH and ACTH secretion which assesses hypothalamic function.”
BackgroundGordon, M., Levy, R., Gut, R., & Germak, J. (2016) · Endocrine Practice · doi:10.4158/ep14603.or · Cited by 20
Yuen, K. C. J., Bennett, R. M., Hryciw, C. A., Cook, M. B., Rhoads, S. A., & Cook, D. M. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.12.006 · Cited by 24
Self-citationYuen, K. C. J. (2011) · ISRN Endocrinology · doi:10.5402/2011/608056 · Cited by 24
Growth Hormone and Prader-Willi Syndrome
Carrel, A. L., Lee, P., & Mogul, H. R. (2006) · Springer eBooks · doi:10.1007/978-0-387-33536-0_7 · Cited by 26
Corneli, G., Baldelli, R., Somma, C. D., Rovere, S., Gaia, D., Pellegrino, M., Gasco, V., Durante, C., Grottoli, S., Colao, A., et al. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00010-8 · Cited by 25
Hypopituitarism in the elderly
Antonopoulou, M., Sharma, R. K., Farag, A., Banerji, M. A., & Karam, J. G. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.05.002 · Cited by 23
“[64] Biller BM, Samuels MH, Zagar A, et al.”
BackgroundPetryk, A., Baker, K. S., Frohnert, B. I., Moran, A., Chow, L. S., Sinaiko, A. R., Steffen, L. M., Perkins, J. L., Zhang, L., Hodges, J. S., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24308 · Cited by 24
“Some stimulation tests carry a risk of hypoglycemia (insulin tolerance test) [44], some can no longer be performed because the stimulant is no longer manufactured (GHRH) [45], and some require overnight hospitalization (continuous overnight GH monitoring) with no clear advantage over stimulated GH response [46].”
BackgroundIkeda, H., Gotoh, H., & Watanabe, K. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00025 · Cited by 23
Zgaljardic, D. J., Guttikonda, S., Grady, J. J., Gilkison, C. R., Mossberg, K. A., High Jr, W. M., Masel, B. E., & Urban, R. J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03935.x · Cited by 22
Medical Management of Hypopituitarism in Patients with Pituitary Adenomas
Arafah, B. M. (2002) · Pituitary · doi:10.1023/a:1022316631809 · Cited by 25
“Measurements of serum GH levels during insulin-induced hypoglycemia or after an infusion of arginine alone or in combination with synthetic GHRH are the most reliable tests to assess GH secretion [15,16].”
BackgroundSelf-citationThe impact of traumatic brain injury on pituitary function
Sundaram, N. K., Geer, E. B., & Greenwald, B. D. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.003 · Cited by 22
Approach to Testing Growth Hormone (GH) Secretion in Obese Subjects
POPOVIC, V. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1099 · Cited by 23
Garrahy, A., & Agha, A. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0117-7 · Cited by 23
“The test has the advantage of also robustly assessing growth hormone (GH) production [29].”
BackgroundGasco, V., Ferrero, A., Bisceglia, A., Prencipe, N., Cambria, V., Bioletto, F., Ghigo, E., Maccario, M., & Grottoli, S. (2020) · Neuroendocrinology · doi:10.1159/000508103 · Cited by 24
Chanson, P., Cailleux-Bounacer, A., Kuhn, J.-M., Weryha, G., Chabre, O., Borson-Chazot, F., Dubois, S., Vincent-Dejean, C., Brue, T., Fedou, C., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0295 · Cited by 22
Aimaretti, G., Attanasio, R., Cannavò, S., Nicoletti, M. C., Castello, R., Di Somma, C., Garofalo, P., Iughetti, L., Loche, S., Maghnie, M., et al. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0201-7 · Cited by 22
“The glucagon test is used in some centres, although it has never been validated in the transition period [30, 31].”
MethodRussell, M., Bredella, M. A., Tsai, P., Mendes, N., Miller, K. K., Klibanski, A., & Misra, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0380 · Cited by 23
“A fasting GHRH and arginine stimulation test was performed the following morning to evaluate maximal GH secretory capacity (20, 21).”
MethodPetryk, A., Polgreen, L. E., Zhang, L., Hodges, J. S., Dengel, D. R., Hoffmeister, P. A., Steinberger, J., & Baker, K. S. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.156 · Cited by 21
Depth and duration of hypoglycaemia achieved during the insulin tolerance test
Ajala, O., Lockett, H., Twine, G., & Flanagan, D. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0068 · Cited by 23
Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis
Bredella, M. A., Utz, A. L., Torriani, M., Thomas, B. J., Schoenfeld, D., & Miller, K. K. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90998.2008 · Cited by 21
“GH deficiency was based on standard criteria used to diagnose adults with hypopituitarism (peak GH after stimulation with GHRH and arginine 5 ng/ml) (6).”
MethodInfluentialThe diagnosis and treatment of growth hormone deficiency in adults
Clemmons, D. R. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833b6bc7 · Cited by 22
Aimaretti, G., Corneli, G., Somma, C. D., Baldelli, R., Gasco, V., Rovere, S., Migliaretti, G., Colao, A., Tamburrano, G., Lombardi, G., et al. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345381 · Cited by 22
Does Imatinib Mesylate Therapy Cause Growth Hormone Deficiency?
Kebapçılar, L., Bilgir, O., Alacacıoğlu, İ., Payzın, B., Bilgir, F., Öner, P., Sarı, İ., Çalan, M., & Binicier, Ö. (2009) · Medical Principles and Practice · doi:10.1159/000226288 · Cited by 21
“Chronic fatigue is a common and unexplained side effect of imatinib mesylate. In that context, the present study was undertaken to examine the effect of imatinib mesylate on GH secretion in CML subjects. Subjects and MethodsSeventeen patients were included in the study (11 males and 6 females; age, 47.52 ± 9.76 years;…”
Influentialvan Nieuwpoort, I. C., van Bunderen, C. C., Arwert, L. I., Franken, A. A. M., Koppeschaar, H. P. F., van der Lelij, A. J., Twisk, J. W. R., Boers, M., & Drent, M. L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0914 · Cited by 23
Pellecchia, M. T., Pivonello, R., Salvatore, E., Faggiano, A., Barone, P., Michele, G. D., Lombardi, G., Colao, A., & Filla, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02237.x · Cited by 21
Management of Adult Growth Hormone Deficiency
Johannsson, G. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.11.012 · Cited by 24
“Among the validated tests, the insulin tolerance test (ITT), arginine-GH releasing hormone (Arg-GHRH), GHRH-GH releasing peptide (GHRP)–6, and GHRH-pyridostigmine are excellent, whereas clonidine and L-Dopa are inadequate [10].”
BackgroundA 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real Life
Aversa, L. S., Cuboni, D., Grottoli, S., Ghigo, E., & Gasco, V. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206079 · Cited by 25
Testing Growth Hormone Deficiency in Adults
Gabellieri, E., Chiovato, L., Lage, M., Castro, A. I., & Casanueva, F. F. (2010) · Frontiers of hormone research · doi:10.1159/000318503 · Cited by 21
Brabant, G. E., Rasmussen, Å. K., Biller, B. M. K., Buchfelder, M., Feldt‐Rasmussen, U., Forssmann, K., Jönsson, B., Kołtowska‐Häggström, M., Maiter, D. M., Saller, B., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0153 · Cited by 21
Self-citationHoldaway, I. M., Hunt, P. J., Manning, P. J., Cutfield, W. S., Gamble, G. D., Ninow, N., Staples‐Moon, D., Moodie, P. M., & Metcalfe, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12691 · Cited by 20
POPOVIC, V. M., Pekić, S., Doknić, M., Micić, D., Damjanovic, S. S., Žarković, M., Aimaretti, G., CORNELI, G., Ghigo, E., Deiguez, C., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01835.x · Cited by 24
“In the study of Biller et al. (2002), the control subjects for the arginine + GHRH test had higher BMI (30·3 ± 5·8 kg/m2), and the peak serum GH cut-off point was 4·6 µg/l.”
BackgroundFeldt‐Rasmussen, U., Brabant, G. E., Maiter, D. M., Jönsson, B., Toogood, A. A., Kołtowska‐Häggström, M., Rasmussen, Å. K., Buchfelder, M., Saller, B., & Biller, B. M. K. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0005 · Cited by 19
Self-citationValassi, E., Brick, D. J., Johnson, J. C., Biller, B. M. K., Klibanski, A., & Miller, K. K. (2012) · Endocrine Practice · doi:10.4158/ep11134.or · Cited by 19
“For the insulin tolerance test and the growth hormone-releasing hormone-arginine test, standard testing protocols, as previously reported (16), were used.”
MethodSelf-citationPreoperative assessment for pituitary surgery
Pereira, O., & Bevan, J. S. (2008) · Pituitary · doi:10.1007/s11102-008-0093-7 · Cited by 19
“reported on the sensitivity and specificity of six tests (ITT, Arginine-GHRH, Arginine-L-Dopa, Arginine, L-Dopa and IGF-1) in normal subjects and patients with minor and major degrees of anterior hypopituitarism [17].”
BackgroundGrowth hormone levels in the diagnosis of growth hormone deficiency in adulthood
Corneli, G., Gasco, V., Prodam, F., Grottoli, S., Aimaretti, G., & Ghigo, E. (2007) · Pituitary · doi:10.1007/s11102-007-0031-0 · Cited by 22
“[42], who found that a cut-off level of 0.”
InfluentialSavastano, S., Angrisani, L., Somma, C. D., Rota, F., Savanelli, M. C., Cascella, T., Orio, F., Lombardi, G., & Colao, A. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9926-3 · Cited by 20
“In obese patients, either 24-h spontaneous GH secretion or stimulated GH release or both are impaired, including GH secretion in response to all traditional pharmacological stimuli acting on the hypothalamus, such as insulin-induced hypoglycemia or arginine (ARG), and/or targeting directly the somatotrophs by exogenou…”
BackgroundQing, L., Wei, R., Chan, L., Zheng, X., & Xin, X.-J. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0621-2 · Cited by 19
“GH secretion of subjects were evaluated by insulin tolerance test, the gold standard for diagnoses of adult GH deficiency [12, 13].”
MethodGrowth hormone replacement for adult growth hormone deficiency
Shimon, I. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.11.1977 · Cited by 18
“A diagnosis of adult GHD in patients with known pituitary disease or previous growth retardation in childhood is established by provocative tests of GH secretion (insulin tolerance test, GHRH, arginine, glucagon), when peak GH response achieved is < 3 μg/l in one or two tests and may be supported by a low serum IGF-I…”
MethodSchneider, H. J., Herrmann, B. L., Schneider, M., Sievers, C., Schaaf, L., & Stalla, G. K. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02258 · Cited by 17
“Additionally, we also considered the cut-offs of % 5.1 and % 4.1 ng/ml for the ITT and GHHR C ARG respectively as suggested by Biller et al. (2002).”
InfluentialAnterior pituitary hormone replacement therapy—a clinical review
Auernhammer, C. J., & Vlotides, G. (2007) · Pituitary · doi:10.1007/s11102-007-0001-6 · Cited by 17
“5 lg/l [122–127].”
Experience of a Pituitary Clinic for US Military Veterans With Traumatic Brain Injury
Lee, J., Anderson, L. J., Migula, D., Yuen, K. C. J., McPeak, L., & Garcia, J. M. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab005 · Cited by 17
“If a GST was performed, a diagnosis of AGHD was established if the peak GH was less than 3 ng/mL for those with a BMI of 25 or less, or less than 1 ng/mL in those with overweight (BMI = 25-30) or obesity (BMI > 30) [13, 17-19].”
BackgroundMarzullo, P., Marcassa, C., Minocci, A., Campini, R., Eleuteri, E., Gondoni, L. A., Aimaretti, G., Sartório, A., Scacchi, M., & Grugni, G. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1063 · Cited by 18
The accuracy of diagnostic tests for GH deficiency in adults: a systematic review and meta-analysis
Hazem, A., Elamin, M. B., Malaga, G., Bancos, I., Prevost, Y., Zeballos-Palacios, C., Velasquez, E. R., Erwin, P. J., Natt, N., Montori, V. M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0476 · Cited by 16
Insulin like growth factor-I in acute subarachnoid hemorrhage: a prospective cohort study
Bendel, S., Koivisto, T., Ryynänen, O., Ruokonen, E., Romppanen, J., Kiviniemi, V. V., & Uusaro, A. V. (2010) · Critical Care · doi:10.1186/cc8988 · Cited by 16
Diagnostic value of a ghrelin test for the diagnosis of GH deficiency after subarachnoid hemorrhage
Blijdorp, K., Khajeh, L., Ribbers, G. M., Sneekes, E. M., Heijenbrok‐Kal, M. H., van den Berg-Emons, R. J. G., van der Lely, A. J., van Kooten, F., & Neggers, S. J. C. M. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0436 · Cited by 17
The robustness of diagnostic tests for GH deficiency in adults
Andersen, M. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.03.001 · Cited by 18
Giritharan, S., Cox, J., Heal, C., Hughes, D., Gnanalingham, K. K., & Kearney, T. (2017) · Pituitary · doi:10.1007/s11102-017-0825-7 · Cited by 17
“Even other stimulatory tests, such as the insulin tolerance test (ITT) and growth hormone releasing hormone (GHRH)-arginine stimulation test, show that GH response is BMI dependent [44, 45].”
BackgroundBerberoğlu, M., Şıklar, Z., Darendelıler, F., Poyrazoğlu, Ş., Darcan, Ş., İşgüven, P., Bıdecı, A., Öçal, G., Bundak, R., Yüksel, B., et al. (2008) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4008/jcrpe.v1i1.7 · Cited by 16
“(9, 11) Because of the risks associated with hypoglycemia, currently GHRH-arginine test is an alternative to ITT.”
BackgroundGrowth hormone reserve in adult beta thalassemia patients
Ledergor, G., Goldfarb, A. W., Gläser, B., & Dresner–Pollak, R. (2007) · Endocrine · doi:10.1007/s12020-007-0018-7 · Cited by 16
Bogazzi, F., Manetti, L., Lombardi, M., Giovannetti, C., Raffaelli, V., Urbani, C., Scattina, I., Pepe, P., Iannelli, A., Martino, E., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1068 · Cited by 17
Growth Hormone: The Expansion of Available Products and Indications
Franklin, S. L., & Geffner, M. E. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.07.006 · Cited by 19
“Because IGF-1 levels are normal in a significant number of adults who have GHD (unlike most of their pediatric counterparts), GH stimulation testing remains paramount in securing the diagnosis of AGHD (Table 2).(80) Several additional caveats must be considered when attempting to diagnose GHD in adults.”
BackgroundSamarasinghe, S., Emanuele, M. A., & Mazhari, A. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4087-0.00047-4 · Cited by 15
“The best two tests for diagnosis of GH deficiency are the insulin tolerance test and the growth hormone-releasing hormone (GHRH) arginine test (Biller et al., 2002).”
MethodYackobovitch‐Gavan, M., Lazar, L., Diamant, R., Phillip, M., & Oron, T. (2020) · Hormone Research in Paediatrics · doi:10.1159/000513393 · Cited by 17
Ali, A., Hashim, R., Khan, F. A., Sattar, A., Ijaz, A., Manzoor, S. M., & Younas, M. (2009) · PubMed · Cited by 15
Evaluation of Endocrine Function
Guber, H. A., & Farag, A. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00024-5 · Cited by 19
Deutschbein, T., Bidlingmaier, M., Schopohl, J., Strasburger, C. J., & Petersenn, S. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0668 · Cited by 16
Metadata
- Authors
- Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L.
- Affiliations
- Harvard University (US)
- Oregon Health & Science University (US)
- University Hospitals of Cleveland (US)
- Cedars-Sinai Medical Center (US)
- NYU Langone Health (US)
- Corresponding author
- Biller, Beverly M. K.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-05-01
- Volume
- 87
- Issue
- 5
- Pages
- 2067-2079
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2125896595
- Semantic Scholar
- e5209f92424ddb2dfc412b4606bcb9a11bff13d5
- Cited by
- 423
- References
- 64
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 16 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 18 · 2019: 15 · 2018: 9 · 2017: 15 · 2016: 14 · 2015: 25 · 2014: 17 · 2013: 19 · 2012: 17
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- insulin tolerance test, arginine stimulation test, GHRH stimulation test, diagnostic thresholds, sensitivity and specificity, multiple pituitary hormone deficiency, hypothalamic-pituitary disease, insulin-like growth factor I, diagnostic accuracy comparison, pituitary hormone replacement
- MeSH terms
- Adult, Aged, Aging, Arginine, Diagnostic Techniques, Endocrine, Drug Combinations, Female, Humans, Hypoglycemic Agents, Insulin, Insulin-Like Growth Factor I, Levodopa, Male, Metabolic Diseases, Middle Aged, Sensitivity and Specificity, Sex Characteristics, Growth Hormone-Releasing Hormone, Stimulation, Chemical, Body Mass Index, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.